Introduction {#sec1-1}
============

Obesity in young populations is on the increase due to changes in nutrition behaviors and lifestyle. In Egypt, obese subjects represented about 15.6 % of adolescents aged 10-19 in 2017. Egypt is predicted to rank as the sixth country suffering of having high number of obese subjects (6,818,532) aged 5-19 years in 2030 \[[@ref1]\], \[[@ref2]\].

Obese children and obese adolescents are also more prone to have hyperlipidemia, hypertension, type 2 diabetes and metabolic syndrome (MS). The widespread of obesity among children, leads to the increased occurrence of MS in them. The metabolic syndrome has been reported in young populations in Egypt and other countries \[[@ref3]\], \[[@ref4]\]. Several authors have reported the prevalence of the metabolic syndrome in children \[[@ref5]\], \[[@ref6]\]. There is no consensus about the definition of MS in children \[[@ref7]\]. Magge et al., reported that focusing on the screening and treating the individual risk factor components of MS and cardio metabolic risk factor was emphasized over the need to define a pediatric MS \[[@ref8]\].

The most commonly used criteria in different studies are the modified WHO, Cook and the IDF consensus criteria \[[@ref9]\], \[[@ref10]\]. MS is a cluster of cardiovascular risk factors associated with insulin resistance and are driven by several factors, including visceral obesity \[[@ref11]\].

The body mass index (BMI) is a good index to diagnose general obesity, but it does not reflect fat distribution or differentiate muscle and fat masses. Waist circumference (WC) has been suggested as an alternative to BMI. It is a parameter of abdominal obesity. However, many studies have showed that WC is highly correlated to BMI; so, its value per se is limited. To solve these problems, new anthropometric parameters were developed \[[@ref12]\]. Efforts should be made for recognition of this metabolic risk.

Among the new obesity anthropometric parameters (body round index \[BRI\], visceral adiposity index \[VAI\]) and a body shape index \[ABSI\], were found to be significantly associated with arterial stiffness in adult \[[@ref13]\].

The visceral adiposity index (VAI), is a sex-specific indicator of visceral fat distribution which depends on BMI, WC, triglyceride and high-density lipoprotein-cholesterol (HDL-C) \[[@ref14]\].

A body shape index (ABSI), using a standardized WC based on BMI and height, reflects mortality hazard better than BMI and WC \[[@ref15]\]. While, the body roundness index (BRI), is an indicator of body fat and visceral adipose tissue percentage, and may be useful for evaluating health status \[[@ref15]\].

To the best of our knowledge, no study analyzing the cross-sectional relationships between these new anthropometric parameters, obesity, blood pressure, insulin resistance, and other markers of the MS in childhood. The present study aimed to evaluate these new parameters of obesity in children and their possible association with other laboratory and clinical variables of MS.

Materials and Methods {#sec1-2}
=====================

Study Population {#sec2-1}
----------------

We performed a cross-sectional study. The study protocol was approved by the Human Ethics Committee of National Research Center, and written informed consent was obtained from children's caregivers (Approval No14019) . We enrolled 89 obese children (30 male, 59 female); they were attending the Pediatrics Obesity Clinic in Centre of Excellence in National Research Centre, with age range from 10 to 18 years. A child was obese if BMI \> 95th percentile for age and gender percentile curves of growth for our population \[[@ref16]\].

The obese subjects were divided into two groups: first group included patients with metabolic syndrome. We used the IDF definition of MS for children aged 10 years or older which includes BMI\>90th percentile for age and sex and presence of two or more of the following findings: (1) triglycerides \>150 mg/dl; (2) HDL-cholesterol \<40 mg/dl; (3) systolic blood pressure \>130 mmHg, diastolic \>85 mmHg; and (4) fasting plasma glucose \>100 mg/dl or known type 2 diabetes \[[@ref14]\], a second group includes patients without MS.

Exclusion criteria: medical conditions associated with obesity such as cardiac, hepatic or renal diseases, hypothyroidism, Cushing syndrome or Turner syndrome, also obesity with mental retardation, such as Prader-Willi syndrome, Laurence-Moon- Biedl and Cohen syndrome.

A control group included 40 children (25 male, 15 female); they were age-matched healthy subjects.

Clinical Examination {#sec2-2}
--------------------

The following were performed on the studied groups:

1\) Full history taking through clinical examination, with emphasis on any complications or medication; 2) Blood pressure was measured according to American Heart Association guidelines; three times for patients and controls after 5-min rest in sitting position with the use of mercury sphygmomanometer. The mean value of 2nd and 3rd measurement was calculated. SBP was defined as the onset of the Korotkoff sound (K1), and DBP was defined as the fifth Korotkoff sound (K5); and 3) Anthropometric indices: Body weight measured to the nearest 0.1 kg with a balance scale and height measured to the nearest 0.1 cm. Body mass index was calculated as weight divided by height squared (kg/m2). Waist circumference (WC) was measured at the level midway between the lowest rib margin and the iliac crest. Hip circumference (HIP C) was measured at the widest level over the greater trochanters in a standing position by the same examiner; then waist to hip ratio (WHR) and Waist to height ratio (WHtR) were calculated.

Among the new obesity anthropometric parameters: body round index (BRI), and visceral adiposity index (VAI) and a body shape index (ABSI) were calculated by the following equations \[[@ref9]\].
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TG, and HDL-C levels are expressed in mmol/L, and WC in expressed in cm \[[@ref9]\], \[[@ref13]\].

Abdominal Ultrasonography {#sec2-3}
-------------------------

In addition to the routine abdominal ultrasound examination based on the clinical indication, ultrasonography (US) distinctively quantifies visceral fat and subcutaneous fat. We measured the maximum pre peritoneal visceral fat thickness (VFT) and the minimum subcutaneous fat thickness (SFT) by US. The visceral fat thickness (VFT) was measured by 3.5-5 MHz convex-array probe. VFT is the distance between the internal surface of the abdominal surface of abdominal muscle and the anterior wall of the aorta 1 cm above the umbilicus. The thickness of subcutaneous fat was measured by placement of a 3.75-MHz probe perpendicular to the skin on the epigastrium. Longitudinal scans are obtained along the middle line (linea Alba). The thickness of the subcutaneous fat is defined as the distance between the anterior surface of linea Alba and the fat-skin barrier \[[@ref17]\], \[[@ref18]\]. Ultrasound apparatus model is SA --R3 (No S06YM3 HDC00012F) SAMSUNG MEDISON Company --South Korea.

Laboratory measurements {#sec2-4}
-----------------------

Ten millimeters of venous blood were withdrawn under complete aseptic precautions from fasting subjects (12-14 hrs.). Samples were labeled and left to clot at room temperature for 15 min then centrifuged, sera were collected and aliquoted for evaluation of the following parameters: 1) Determination of complete lipid profile (serum triglycerides, HDL, LDL cholesterol) was done using colorimetric methods on Olympus AU 400 supplied from Olympus Life and Material Science (Europe GmbH, Wendenstraße, Hamburg, Germany); 2) Fasting blood glucose was assessed using Hitachi 912 chemistry analyzer (Roche Diagnostics GmbH, D-68298 Mannheim, Germany) by colorimetric techniques; 3) Insulin levels were estimated by Enzyme immunoassay (ELISA); 4) Insulin resistance was calculated by the homeostasis model (HOMA-IR) using the following formula: HOMA-IR = fasting insulin (mU/L) × fasting glucose (mmoL/L)/22.5; and 5) Glycosylated Hb (HbA1c) was measured using ion exchange HPLC (high performance liquid chromatography) Kit supplied by Crystal Chem, USA.

Statistical analysis {#sec2-5}
--------------------

The standard computer program Statistical Package for the Social Sciences (SPSS) for Windows, release 17.0 (SPSS Inc., USA) was used for data entry and analysis. All numeric variables were expressed as mean ± standard deviation (SD). Comparison between groups was made using Student t test for continuous variables and Chi-Square tests for categorical variables. Pearson's and Spearman's correlation tests (r = correlation coefficient) were used for correlating normal and non-parametric variables respectively. The receiver operating characteristic (ROC) curve was generated to detect the predictive capabilities of BMI, ABSI, BRI, VAI for MS. P \< 0.05 was considered statistically significant.

Results {#sec1-3}
=======

There were no significant differences between obese subjects (with & without MS) and control groups in terms of age (p \> 0.05). Obese children -the characteristics of the three subgroups are included in [Table 1](#T1){ref-type="table"}, and [Table 2](#T2){ref-type="table"}. Regarding clinical data, [Table 1](#T1){ref-type="table"} revealed statistically significant difference between studied groups in BMI, WC, WHtR, Systolic BP and Diastolic BP (P = 0.000, 0.000, 0.000, \< 0.001 & 0.000, respectively) . Also other measurements by abdominal ultrasonography (SFT, VFT & liver size) showed same results (P = 0.000, 0.002, 0.000, respectively).

###### 

Characteristics of the studied population

  Item            Subgroups   N          Mean      Std. Deviation   ANOVA
  --------------- ----------- ---------- --------- ---------------- -------
  Age Years       No MS       67         11.449    2.6169           0.432
  MS              22          11.923     2.7526                     
  Controls        40          10.65      4.3597                     
  BMI (kg/m2)     No MS       67         24.1227   8.56             0.000
  MS              22          38.2623    6.63                       
  Controls        40          17.92      4.17                       
  WC CM           No MS       67         78.6753   22.19            0.000
  MS              22          104.8462   11.68                      
  Controls        40          69.68      18.56                      
  WHtR            No MS       67         0.469     0.16             0.699
  MS              22          0.5877     0.10                       
  Controls        40          0.46       0.08                       
  WHtR            No MS       67         0.55      0.15             0.000
  MS              22          0.77       0.10                       
  Controls        40          0.43       0.11                       
  Systolic BP     No MS       67         95.01     19.87            0.001
  MS              22          117.08     12.51                      
  Controls        40          89.74      16.97                      
  Diastolic BP    No MS       67         63.82     8.381            0.000
  MS              22          77.92      10.544                     
  Controls        40          61.67      8.683                      
  SFT \[cm\]      No MS       67         1.53      0.74             0.000
  MS              22          2.70       0.68                       
  Controls        40          1.29       0.50                       
  VFT \[cm\]      No MS       67         3.44      1.51             0.002
  MS              22          4.83       1.66                       
  Controls        40          2.53       o.93                       
  Liver Size CM   No MS       67         13.00     1.88             0.000
  MS              22          15.75      1.07                       
  Controls        40          11.39      1.90                       

No MS = No metabolic syndrome; MS = Metabolic Syndrome; (SBP) Systolic blood pressure; (DBP) diastolic blood pressure; (SFT), subcutaneous fat thickness; (VFT) visceral fat thickness; (WC) Waist circumference; (BMI) Body mass index; (WHtR) Waist to height ratio; (WHR) waist to hip ratio.

###### 

Laboratory results of the studied population

  Item                       Subgroups   N        Mean     Std. Deviation   ANOVA SIG
  -------------------------- ----------- -------- -------- ---------------- -----------
  FBG \[mg/dl\]              No MS       67       82.00    28.23            0.986
  MS                         22          83.23    14.26                     
  Controls                   40          81.47    10.92                     
  HOMA_IR                    No MS       67       2.47     1.70             0.000
  MS                         22          4.48     1.309                     
  Controls                   40          2.19     1.517                     
  HgA1C                      No MS       67       5.65     0.610            0.315
  MS                         22          5.95     0.777                     
  Controls                   40          5.77     0.617                     
  Fasting Insulin \[mU/l\]   No MS       67       13.86    9.079            0.028
  MS                         22          21.72    4.362                     
  Controls                   40          12.86    11.536                    
  Cholesterol \[mg/dl\]      No MS       67       157.78   30.68            0.064
  MS                         22          176.15   38.71                     
  Controls                   40          161.47   36.54                     
  Triglycerides \[mg/dl\]    No MS       67       88.59    32.00            0.143
  MS                         22          108.15   46.32                     
  Controls                   40          84.23    28.24                     
  HDL \[mg/dl\]              No MS       67       53.37    15.90            0.003
  MS                         22          37.61    10.79                     
  Controls                   40          54.42    14.21                     
  LDL \[mg/dl\]              No MS       67       86.14    29.55            .004
  MS                         22          116.84   36.35                     
  Controls                   40          101.27   33.89                     

No MS = No metabolic syndrome; MS = Metabolic Syndrome; FBG = Fasting blood glucose; HOMA-IR = the homeostasis model assessment; HDL = High-density lipoprotein; LDL = Low-density lipoprotein, HbA1C Glycosylated Hb.

In the studied groups, our laboratory parameters data exhibited significant difference in HOMA-IR values, fasting insulin, HDL & LDL (P = 0.000, 0.028, 0.003, 0.004). Further details are in [Table 2](#T2){ref-type="table"}.

Among the new obesity indices, ABSI, BRI and VAI have been found to be significantly higher in obese subjects (P \< 0.001) ([Table 3](#T3){ref-type="table"}). Additionally, we found no significant gender difference in all studied items.

###### 

New anthropometric parameters of obese& non-obese children

  Item    Group      N      Mean   Std. Deviation   Sig. (2-tailed)
  ------- ---------- ------ ------ ---------------- -----------------
  ABSI    Controls   40     7.58   1.31             0.001
  Obese   89         5.49   3.02                    
  BRI     Controls   40     4.28   2.28             0.001
  Obese   89         9.14   8.29                    
  VAI     Controls   39     1.63   0.95             0.001
  Obese   89         3.41   3.03                    

(ABSI) a body shape index; (BRI) body round index; (VAI) visceral adiposity index.

In addition, we found that 24.75% (22 subjects, 17 females & 5 males) of the obese children aged 10-16 years met the criteria for MS based on the pediatric MS definition of the IDF consensus. [Table 4](#T4){ref-type="table"} shows the differences between obese with & without MS. BMI, WHtR, WC/HipR, SBP, DBP, SFT, VFT, Liver Span, ABSI, BRI, VAI and HOMA_IR were significantly higher among children with MS than those without MS.

###### 

Comparison between obese children with & without MS

                                        N        Mean     Std. Deviation   Sig. (2-tailed)
  ------------------------ ------------ -------- -------- ---------------- -----------------
  ABSI                     Without MS   67       4.79     3.17             0.001
  With MS                  22           7.64     0.52                      
  BRI                      Without MS   67       8.11     7.38             0.041
  With MS                  22           12.26    10.16                     
  VAI                      Without MS   67       2.42     1.95             0.001
  With MS                  22           6.43     3.71                      
  BMI (kg/m2)              Without MS   67       31.90    5.92             0.001
  With MS                  22           38.61    5.85                      
  WC cm                    Without MS   67       92.80    11.07            0.001
  With MS                  22           104.72   11.39                     
  Whtr                     Without MS   67       0.61     0.13             0.005
  With MS                  22           0.70     0.08                      
  WHR                      Without MS   67       0.67     0.12             0.002
  With MS                  22           0.76     0.11                      
  Systolic BP mm Hg        Without MS   67       105.85   10.50            0.001
  With MS                  22           116.25   11.57                     
  Diastolic BP mm Hg       Without MS   67       67.36    8.24             0.001
  With MS                  22           80.25    9.10                      
  HOMA_IR                  Without MS   67       2.83     1.69             0.001
  With MS                  22           4.53     1.20                      
  SFT cm                   Without MS   67       2.12     0.57             0.001
  With MS                  22           2.91     0.92                      
  VFT cm                   Without MS   67       4.58     1.28             0.001
  With MS                  22           5.92     1.73                      
  Liver Span cm            Without MS   67       14.13    1.64             0.001
  With MS                  22           15.86    1.31                      
  Triglyceride \[mg/dl\]   Without MS   67       90.83    24.06            0.001
  With MS                  22           112.95   47.25                     
  HDL \[mg/dl\]            Without MS   67       56.01    26.31            0.014
  With MS                  22           41.34    17.99                     

(SBP) Systolic blood pressure; (DBP) diastolic blood pressure (SFT); subcutaneous fat thickness; (VFT) visceral fat thickness; (WC) Waist circumference; (HDL) High-density lipoprotein.

Correlations between ABSI, BRI and VAI and the studied variables in obese subjects are shown in [Table 5](#T5){ref-type="table"}. Results showed positive significant correlations of VAI with BMI, WC/Ht, WC/Hip, SBP, DBP, SET, VFT, Liver size and HOMA-IR (r = 0.384, 0.239, 0.268, 0.329, 0.516, 0.320, 0.254, 0.251, and 0.278, respectively). While, BRI had statistically significantly positive correlation with BMI, WC/Ht and HOMA-IR (r = 0.343, 0.234, and 0.322, respectively). ABSI had statistically significantly positive correlation with WC/Ht only, (r = 0.220).

###### 

Correlations between the studied variables in obese subjects

         BMI     WC/ Ht                                    WC/Hip                                  SBP                                     DBP                                       SFT                                       VFT                                       Liver size                              HOMA-IR                                 
  ------ ------- ----------------------------------------- --------------------------------------- --------------------------------------- ----------------------------------------- ----------------------------------------- ----------------------------------------- --------------------------------------- --------------------------------------- -----------------------------------------
  VAI    r       0.384[\*\*](#t5f1){ref-type="table-fn"}   0.239[\*](#t5f2){ref-type="table-fn"}   0.268[\*](#t5f2){ref-type="table-fn"}   0.329[\*\*](#t5f1){ref-type="table-fn"}   0.516[\*\*](#t5f1){ref-type="table-fn"}   0.320[\*\*](#t5f1){ref-type="table-fn"}   0.254[\*](#t5f2){ref-type="table-fn"}   0.251[\*](#t5f2){ref-type="table-fn"}   0.278[\*\*](#t5f1){ref-type="table-fn"}
  P      0.000   0.024                                     0.012                                   0.004                                   0.000                                     0.004                                     0.023                                     0.022                                   0.008                                   
  ABSI   r       0.002                                     0.220[\*](#t5f2){ref-type="table-fn"}   -0.075                                  0.102                                     0.163                                     0.035                                     0.079                                   0.036                                   0.066
  P      0.984   0.039                                     0.491                                   0.390                                   0.169                                     0.760                                     0.488                                     0.747                                   0.537                                   
  BRI    r       0.343[\*\*](#t5f1){ref-type="table-fn"}   0.234[\*](#t5f2){ref-type="table-fn"}   0.181                                   0.123                                     0.144                                     0.097                                     0.047                                   0.062                                   0.322[\*\*](#t5f1){ref-type="table-fn"}
  P      0.001   0.028                                     0.093                                   0.298                                   0.225                                     0.395                                     0.678                                     0.580                                   0.002                                   

Correlation is significant at the 0.01 level (2-tailed);

correlation is significant at the 0.05 level.

The receiver operating characteristic (ROC) curve was generated to detect the predictive capabilities of BMI, WC/Ht R, WC/Hip R, VAI, ABSI, and BRI for predicting MS ([Figure 1](#F1){ref-type="fig"}, and Figure 2).

![ROC Curves of BMI, WCHt R and WCHip R (left); ROC Curves of ABSI, BRI, and VAI (right)](OAMJMS-7-3930-g002){#F1}

The area under the ROC curve (AUC) of BMI, VAI, ABSI, BRI for predicting MS was 0.802 (0.701-0.902), 0.737 (0.633-0.841), 0.737 (0.620-0.855), 0.816 (0.698-0.934), respectively. Details are in [Table 6](#T6){ref-type="table"}.

###### 

Area under the curve in obese children of all studied variables

  Test Result Variables   Area    Std. Error   Sig.    Asymptotic 95% Confidence Interval   
  ----------------------- ------- ------------ ------- ------------------------------------ -------
  BMI                     0.802   0.051        0.000   0.701                                0.902
  W/HtR                   0.730   0.065        0.001   0.604                                0.857
  WHR                     0.720   0.062        0.002   0.599                                0.841
  ABSI                    0.737   0.053        0.001   0.633                                0.841
  BRI                     0.737   0.060        0.001   0.620                                0.855
  VAI                     0.816   0.060        0.000   0.698                                0.934

Null hypothesis: true area = 0.5 & AUC: .90-1 = excellent (A),80-.90 = good (B),.70-.80 = fair (C).

Discussion {#sec1-4}
==========

Obesity is responsible for health burden in children and adolescents in Egypt and all over the world. BMI and WHtR are important indexes for predicting obesity and MS. However, Studies from South Africa reported that WHtR is the best predictor of MS \[[@ref19]\].

BMI and WHtR are limited in differentiating the lean mass from adipose tissue, and are not reflecting lipid accumulation in the circulating blood \[[@ref20]\]. The specific mechanism causing MS has not been established, but, central obesity plays a critical role. It is hypothesized that an excess visceral adipocytes contributes to a pro inflammatory state and insulin resistance and involved with the development of MS \[[@ref21]\], \[[@ref22]\]. Ethnic and racial variation might need different cutoff points or use of different anthropometric measurement to diagnose obesity and MS \[[@ref23]\].

In this study we evaluated and compared old and new anthropometric indices for detecting body adiposity .Seven anthropometric parameters: BMI, WC, WHtR, WHR, VAI, ABSI and BRI were studied. Based on our results all anthropometric parameters assessed, have been found to be significantly higher in obese subjects (P \< 0.001) than controls which is in accordance with other studies \[[@ref3]\].

MS cases showed a group of cardiovascular risk factors including central obesity (measured by high WC or high BMI), high systolic and diastolic pressure, high triglycerides, low HDL, high fasting glucose and high HOMA-IR. Previous studies showed similar results \[[@ref3]\],\[[@ref24]\].

Our results showed, that BMI and WHtR were predictive of obesity and MS. However, they did not reflect lipid accumulation in the circulating blood neither differentiating the lean mass from adipose tissue. Therefore, BMI and WHtR were not the best predictive indices of obesity and MS. These results were in accordance with those of other studies \[[@ref25]\], \[[@ref26]\].

In an attempt for searching of the best predictor of MS, we evaluated new anthropometric parameters of obesity namely; ABSI, BRI,and VAI. ABSI showed a significant ability to predict MS in this study, ABSI showed significant ability to predict MS. ABSI was shown to be a reliable index of fat accumulation as it encompasses waist circumference and BMI.Previous cross-sectional and prospective studies from Iran and china have reported ABSI to be a weak predictor of MS \[[@ref27]\], \[[@ref28]\], \[[@ref29]\].

BRI had statistically significantly positive correlation with BMI, WHtR and HOMA-IR.

Our study showed that BRI was predictive of MS. However, this result remains controversial. One study showed its potential to identify MS andT2 DM, \[[@ref30]\] whereas another study reported that BRI is not better than old obesity parameters in predicting MS \[[@ref31]\].

Recently, visceral adiposity index (VAI) has shown promise as a marker of visceral fat dysfunction. The VAI is based on sex, body mass index (BMI), waist circumference (WC) and metabolic parameters (serum triglycerides and \[HDL-C\] levels. Our study showed positive significant correlations of VAI with BMI, WC/ Ht, WC/Hip, SBP, DBP, SET, VFT, Liver size and HOMA-IR. The VAI showed a strong predictive ability of MS better than BMI and WHtR according to area under the curve (0.816, 0.802, 0.730, with P = 0.000, 0.001, 0.002, respectively). This result was in accordance with those of other studies \[[@ref32]\], \[[@ref33]\], \[[@ref34]\], \[[@ref28]\]. Yang et al., reported that VAI could be a surrogate index for obesity assessment \[[@ref35]\]. Our study is strengthened by the fact that the VAI was established as an index of visceral fat dysfunction. Choi et al showed that the new obesity indices, ABSI and VAI have been found to be significantly associated with arterial stiffness \[[@ref36]\]. MS in childhood predicts adult cardiovascular disease \[[@ref37]\]. MS appears to accelerate the cardiovascular disease process \[[@ref38]\]. Thus, the VAI is very suitable for our subjects. However, there are conflicting data in different populations and ethnicity groups, regarding MS \[[@ref39]\]. Screening for obesity and MS should be incorporated in pediatric clinical care \[[@ref40]\].

*Limitations in the current study:* This study was cross-sectional and there was limited ability to validate causality between the new markers and MS. Studied group was small, and might be insufficient to represent MS in children and adolescents.

In conclusion, the tested anthropometric parameters could predict body fat percent with relatively good power; however VAI, BMI and WHtR indices are more powerful predictors. Based on our findings, we suggest using the VAI and WHtR indices are better predictors of MS. Additional studies with larger obese group are necessary.
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